Elucidating the anti-inflammatory material basis of the Tibetan medicine Tiebangchui by integrating UPLC-Q-Orbitrap MS, serum pharmacochemistry, and a zebrafish model | Synapse
March 3, 2026
Elucidating the anti-inflammatory material basis of the Tibetan medicine Tiebangchui by integrating UPLC-Q-Orbitrap MS, serum pharmacochemistry, and a zebrafish model
Key Points
Anti-inflammatory properties were elucidated using a zebrafish model, indicating potential therapeutic effects.
Key evidence showed significant modulation of inflammatory markers through the integration of UPLC-Q-Orbitrap MS.
Assessment using serum pharmacochemistry techniques highlighted active compounds in Tibetan medicine Tiebangchui.
Understanding the material basis may enable the development of new inflammation treatments, requiring further validation.